EVE Operating Income vs Interest Expense Analysis
EVE Stock | 0 0.00 0.00% |
EVE Health financial indicator trend analysis is much more than just examining EVE Health Group latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether EVE Health Group is a good investment. Please check the relationship between EVE Health Operating Income and its Interest Expense accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Operating Income vs Interest Expense
Operating Income vs Interest Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of EVE Health Group Operating Income account and Interest Expense. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between EVE Health's Operating Income and Interest Expense is -0.46. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Interest Expense in the same time period over historical financial statements of EVE Health Group, assuming nothing else is changed. The correlation between historical values of EVE Health's Operating Income and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of EVE Health Group are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Operating Income i.e., EVE Health's Operating Income and Interest Expense go up and down completely randomly.
Correlation Coefficient | -0.46 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Operating Income
Operating Income is the amount of profit realized from EVE Health Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of EVE Health Group is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Most indicators from EVE Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EVE Health Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Selling General Administrative is likely to drop to about 625.9 K in 2024. Discontinued Operations is likely to drop to about (2 M) in 2024
EVE Health fundamental ratios Correlations
Click cells to compare fundamentals
EVE Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EVE Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.1M | 11.9M | 8.1M | 4.1M | 2.5M | 2.4M | |
Short Long Term Debt Total | 584.3K | 1.0M | 492.4K | 4.3K | 74.9K | 71.1K | |
Other Current Liab | 131.2K | 289.7K | 309.0K | 750.6K | 959.4K | 1.0M | |
Total Current Liabilities | 581.8K | 951.5K | 743.1K | 1.0M | 1.3M | 656.0K | |
Total Stockholder Equity | 13.0M | 10.2M | 6.9M | 3.1M | 1.2M | 1.2M | |
Net Debt | (4.6M) | (2.1M) | (610.0K) | (188.2K) | (31.3K) | (32.9K) | |
Retained Earnings | (20.3M) | (23.8M) | (29.1M) | (33.1M) | (34.8M) | (33.1M) | |
Accounts Payable | 404.8K | 431.5K | 338.4K | 254.2K | 264.8K | 295.4K | |
Cash | 5.1M | 3.2M | 1.1M | 192.5K | 106.2K | 100.9K | |
Non Current Assets Total | 7.3M | 7.2M | 5.4M | 13.2K | 179.0 | 170.05 | |
Non Currrent Assets Other | (217.5K) | (6.9M) | (6.9M) | (5.0M) | (13.2K) | 0.0 | |
Cash And Short Term Investments | 5.1M | 3.2M | 1.1M | 192.5K | 106.2K | 100.9K | |
Net Receivables | 923.5K | 352.4K | 250.7K | 115.7K | 78.7K | 74.8K | |
Common Stock Shares Outstanding | 3.7B | 4.6B | 4.0B | 5.2B | 5.3B | 5.5B | |
Liabilities And Stockholders Equity | 14.1M | 11.9M | 8.1M | 4.1M | 2.5M | 2.4M | |
Non Current Liabilities Total | 76.8K | 722.7K | 538.5K | 784.6K | 396.6K | 0.0 | |
Other Stockholder Equity | (14.8M) | (12.0M) | (8.8M) | (5.0M) | (4.5M) | (4.7M) | |
Total Liab | 1.1M | 1.7M | 1.1M | 1.0M | 1.3M | 835.7K | |
Total Current Assets | 6.8M | 4.7M | 2.7M | 4.1M | 2.5M | 2.8M | |
Accumulated Other Comprehensive Income | 297.5K | 343.3K | 415.3K | 431.9K | 194.0K | 184.3K | |
Common Stock | 33.0M | 33.6M | 35.6M | 35.8M | 41.2M | 43.3M | |
Short Term Debt | 45.8K | 230.3K | 95.7K | 4.3K | 74.9K | 71.1K | |
Property Plant And Equipment Net | 4.8M | 5.2M | 4.5M | 13.2K | 179.0 | 170.05 | |
Property Plant And Equipment Gross | 4.8M | 5.7M | 5.2M | 26.5K | 179.0 | 170.05 | |
Property Plant Equipment | 4.8M | 5.2M | 4.5M | 11.1K | 10.0K | 9.5K | |
Other Current Assets | 303.3K | 202.6K | 201.5K | 3.3M | 2.2M | 2.3M | |
Inventory | 766.6K | 1.2M | 1.4M | 522.9K | 141.5K | 134.5K | |
Net Tangible Assets | 12.0M | 9.3M | 6.8M | 3.1M | 3.6M | 6.4M | |
Long Term Investments | 1.8M | 1.2M | 701.0K | 359.9K | 323.9K | 307.7K | |
Net Invested Capital | 13.5M | 10.7M | 7.4M | 4.6M | 1.3M | 1.2M | |
Cash And Equivalents | 340.3K | 5.1M | 3.2M | 1.1M | 1.3M | 1.2M | |
Net Working Capital | 6.2M | 3.7M | 2.0M | 4.1M | 1.2M | 1.2M | |
Current Deferred Revenue | (45.8K) | (230.3K) | (95.7K) | (1.0) | 326K | 342.3K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EVE Stock Analysis
When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.